Darshan Orna (539884)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue growth of 944.58% shows a substantial expansion in the scale of operations.
• Latest quarter sales of ₹25 Cr suggest the business has revenue momentum.
• Positive book value of ₹2.08 provides some asset backing, and the company is not loss-making on an annual basis.
• ROE and ROCE are positive, albeit low, so there is a baseline of capital efficiency to improve from.

Concerns

• Latest quarter net profit is ₹0 Cr; the trailing P/E of 46.24 is not supported by current earnings.
• Profit growth is -18.18% despite 944.58% sales growth, indicating severe margin compression.
• Piotroski F-Score of 4/9, zero dividend, and undisclosed promoter holding raise governance and financial-quality red flags.
• At 2.06x book with ROE of 2.96%, the valuation is far above the company's ability to create value.

AI Analysis

Looking at Darshan Orna, I am reminded that cheap-looking stocks are not always cheap. At ₹4.29, the market cap is ₹21 crore. The price looks small, but the valuation is not: P/E is 46.24 and P/B is 2.06. The latest quarter had sales of ₹25 crore but net profit of ₹0 crore. That is the heart of my problem. Sales reportedly jumped 944.58%, yet profit growth is minus 18.18%. Where is the benefit of all this extra revenue? It is not reaching shareholders. ROE is only 2.96% and ROCE is 3.58%—far below what I would expect from a jewellery business with any pricing power. A Piotroski score of 4/9 tells me the financial foundation is shaky. There is no dividend, promoter holding is not disclosed, and debt/equity is not available, so I cannot give management credit for financial discipline. Graham would ask: Does this business earn consistently? No. Does it have a margin of safety? At 46 times earnings and 2 times book, no. The only genuine positive is the huge sales expansion, which could indicate a new order or segment. But in a cyclical, low-moat trade like gems and jewellery, revenue without profit is just activity. This is a speculative microcap, not a compounding machine. I would watch whether margins recover, whether ROE can climb to sensible levels, and whether the company starts generating real cash profit. Until then, the prudent desk stays away.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer